Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 13, 2021 at 04:42 am EDT
Share
Autobio Diagnostics Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,677.582 million compared to CNY 1,205.779 million a year ago. Operating income was CNY 457.886 million compared to CNY 316.497 million a year ago. Net income was CNY 412.678 million compared to CNY 273.963 million a year ago. Basic earnings per share from continuing operations was CNY 0.7 compared to CNY 0.49 a year ago.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
AUTOBIO DIAGNOSTICS CO., LTD. 
